Bone Stimulator for Spondylolysis
Launched by THE METHODIST HOSPITAL RESEARCH INSTITUTE · Oct 29, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called bone stimulator therapy for people with a condition known as spondylolysis, which is a type of back problem often seen in athletes. The goal is to see if this therapy can help reduce pain, improve function, help bones heal, and allow athletes to return to their sport more quickly. The study aims to gather important information about how effective this treatment can be for individuals who are active in sports.
To participate in the trial, you need to be between 16 and 40 years old and have been diagnosed with spondylolysis. It's also important that you are planning to attend physical therapy and regularly participate in a sport, whether it’s professional, collegiate, or recreational. However, certain conditions, like having had previous spine surgery or using nicotine products, may prevent you from joining the study. If you decide to participate, you can expect to receive the bone stimulator therapy alongside your regular treatment and will help researchers learn more about its benefits for athletes dealing with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
- • Patients who plan to attend prescribed physical therapy
- • Patients who participate in a regular sport whether that be professional, collegiate or recreational
- Exclusion Criteria:
- • Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
- • Patients with contraindications to bone stimulator therapy
- • Patients with pacemaker and implantable cardioverter defibrillator
- • Patients with previous spine surgery
- • Patients with metabolic bone conditions
- • Patients who use nicotine products
- • Vulnerable populations
- • Non-English speaking services
About The Methodist Hospital Research Institute
The Methodist Hospital Research Institute (MHRI) is a leading clinical research organization dedicated to advancing medical science through innovative research and collaboration. Affiliated with the Methodist Hospital system, MHRI focuses on a broad spectrum of clinical trials, aiming to translate cutting-edge discoveries into effective therapies that enhance patient care. With a commitment to ethical standards and patient safety, the institute fosters partnerships between researchers, clinicians, and industry stakeholders, driving progress in fields such as cancer, cardiology, neurology, and more. Through its robust infrastructure and multidisciplinary approach, MHRI strives to improve health outcomes and contribute to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Mark Prasarn, MD
Principal Investigator
The Methodist Hospital Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported